Plaza del Hospital Civil s/n, Pabellón 4, 1ª Planta
Málaga, 29019, Spain
Location status: Recruiting
NCT Number: NCT07468214
This is an observational study that will be responsible for the Spanish translation and cross-cultural adaptation, and validation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C), to examine, classify, prioritize, and diagnose patients.
Interested in participating?
Request Info6 year–17 year
All sexes
Observational
Málaga, 29019, Spain
Location status: Recruiting
This study, part of the DADAP project, aims to transform the diagnostic evaluation process in the clinical care pathway of child and adolescent psychiatry (CAP) by digitizing and automating it through an innovative solution based on explainable artificial intelligence that optimizes the delivery of health services and care in a wide range of different settings. This study is a real-world, prospective, multicenter, single-arm observational study that has gathered an international consortium formed by Sweden, Norway, Spain, and Romania. Each participating country is responsible for a specific work package.
Our research team is in charge of WP1, which involves the Spanish translation, validation, and cross-cultural adaptation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C). The semi-structured interview EPSI-C was developed in collaboration between the Child and Adolescent Psychiatric Clinic and the Centre for Clinical Research in Region Västmanland, Sweden. It is based on the DSM-5 diagnostic classification, and it will be used to diagnose young people aged 6 to 17.
The Spanish team is also responsible for WP4, which involves validating the feasibility of the EPSI-C tool both across and within countries through a pilot study, integrating new technologies and artificial intelligence to improve diagnostic processes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline
EPSI-C (Electronic Semi-Structured Psychiatric Interview for Children and Adolescents). A semi-structured diagnostic interview that assesses current episodes of psychopathology in children and adolescents aged 6 to 17 years according to the DSM-5 diagnostic criteria. The mental disorders assessed by the EPSI-C are: specific phobia, separation anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD) and complex PTSD (according to ICD-11 criteria), major and persistent depression, manic/hypomanic episode, anorexia nervosa, bulimia nervosa, binge eating disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, Tourette's disorder/tics, oppositional defiant disorder, and conduct disorder. It also includes screening for psychotic disorders and self-harm.
Time frame: At baseline
Questionnaire for the Evaluation of the Content Validity of the EPSI-C. The questionnaire evaluates qualitative assessment (comprehension and wording clarity) and quantitative assessment ( Coherence, clarity, sufficiency, and relevance).
Time frame: At baseline
Ad-hoc patient questionnaire with open-ended items assessing clarity, relevance, comfort, length, and overall satisfaction
Patient-rated satisfaction and acceptability of the culturally adapted EPSI-C after completing the pilot administration.
Time frame: At baseline
Feasibility of EPSI-C measured by mean score on an ad-hoc clinician evaluation form (Likert 1-4).
Clinician-rated acceptability, feasibility, and perceived clinical relevance, clarity, and time length after EPSI-C administration in clinical/pilot settings.
Contact information is provided by the study sponsor or research team.
Irene Lopez Armenteros, PhD student
CONTACT
Marina Romero-González, Doctor
CONTACT
Irene Lopez Armenteros
Other
Acronym: DADAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06493890
Validation Studies
Groningen, Provincie Groningen, Netherlands
View Trial DetailsNCT06581770
Digital Health, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07068503
Behavior, Health Behavior
Cluj-Napoca, Romania
View Trial DetailsNCT01827527
Magnetic Resonance Spectroscopy, Validation Studies
Orlando, Florida, United States
View Trial Details